FineMark National Bank & Trust’s Immunogen Inc IMGN Stock Holding History

FineMark National Bank & Trust’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,000	Closed	-$6K	–	1438
2016 Q2	$6K	Hold	2,000	–	–	﹤0.01%	1054
2016 Q1	$17K	Hold	2,000	–	–	﹤0.01%	809
2015 Q4	$27K	Hold	2,000	–	–	﹤0.01%	759
2015 Q3	$19K	Hold	2,000	–	–	﹤0.01%	861
2015 Q2	$29K	Hold	2,000	–	–	﹤0.01%	795
2015 Q1	$18K	Hold	2,000	–	–	﹤0.01%	903
2014 Q4	$12K	Hold	2,000	–	–	﹤0.01%	996
2014 Q3	$21K	Hold	2,000	–	–	﹤0.01%	883
2014 Q2	$24K	Hold	2,000	–	–	﹤0.01%	861
2014 Q1	$30K	Hold	2,000	–	–	0.01%	766
2013 Q4	$29K	Hold	2,000	–	–	0.01%	725
2013 Q3	$34K	Sell	2,000 -180	-8%	-$3.16K	0.01%	657
2013 Q2	$36K	Buy	+2,180	New	+$35.3K	0.01%	638

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FineMark National Bank & Trust's IMGN Position: Q3 2016 in Review

FineMark National Bank & Trust sold out of Immunogen Inc (IMGN) in Q3 2016, closing a stake of 2,000 shares — an estimated $6K sold.

FineMark National Bank & Trust first reported a position in IMGN in Q2 2013 and held it in 13 quarters. The position peaked at $36K in Q2 2013. 155 funds tracked by Wall St. Rank hold IMGN as of Q3 2016.

FineMark National Bank & Trust reported no remaining Immunogen Inc position as of Q3 2016 after selling out during the quarter.
FineMark National Bank & Trust sold 2,000 Immunogen Inc shares in Q3 2016, an estimated $6K.
FineMark National Bank & Trust first reported a position in Immunogen Inc in Q2 2013 and held it in 13 quarters.
FineMark National Bank & Trust's Immunogen Inc position peaked at $36K in Q2 2013.
155 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2016.

Based on FineMark National Bank & Trust's 13F filing for Q3 2016, filed 10 Nov 2016.